A tale of two ends

Por Towers, Christina G., Ford, Heide L.
Publicado no Cell Cycle (2016)

Clonal cooperativity in heterogenous cancers

Por Zhou, Hengbo, Neelakantan, Deepika, Ford, Heide L.
Publicado no Semin Cell Dev Biol (2016)

Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression

Por Micalizzi, Douglas S., Farabaugh, Susan M., Ford, Heide L.
Publicado em 2010

Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasis

Por Neelakantan, Deepika, Drasin, David J, Ford, Heide L
Publicado no Cell Adh Migr (2014)

Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity

Por Drasin, David J, Robin, Tyler P, Ford, Heide L
Publicado em 2011

Eya2 Is Required to Mediate the Pro-Metastatic Functions of Six1 Via the Induction of TGF-β Signaling, Epithelial-Mesenchymal Transition, and Cancer Stem Cell Properties

Por Farabaugh, Susan M., Micalizzi, Douglas S., Jedlicka, Paul, Zhao, Rui, Ford, Heide L.
Publicado em 2011

Vascular endothelial growth factor C promotes breast cancer progression via a novel antioxidant mechanism that involves regulation of superoxide dismutase 3

Por Wang, Chu-An, Harrell, J Chuck, Iwanaga, Ritsuko, Jedlicka, Paul, Ford, Heide L
Publicado no Breast Cancer Res (2014)

Biochemical and Functional Characterization of Six SIX1 Branchio-oto-renal Syndrome Mutations

Por Patrick, Aaron N., Schiemann, Barbara J., Yang, Kui, Zhao, Rui, Ford, Heide L.
Publicado em 2009

Homeoprotein Six1 Increases TGF–β Type I Receptor and Converts TGF-β Signaling from Suppressive to Supportive for Tumor Growth

Por Micalizzi, Douglas S., Wang, Chu-An, Farabaugh, Susan M., Schiemann, William P., Ford, Heide L.
Publicado em 2010

Distinct TRAIL resistance mechanisms can be overcome by proteasome inhibition but not generally by synergizing agents

Por Menke, Christina, Bin, Lianghua, Thorburn, Jacqueline, Behbakht, Kian, Ford, Heide L., Thorburn, Andrew
Publicado em 2011

MicroRNA-30a regulates zebrafish myogenesis through targeting the transcription factor Six1

Por O'Brien, Jenean H., Hernandez-Lagunas, Laura, Artinger, Kristin Bruk, Ford, Heide L.
Publicado em 2014

The SIX1-EYA transcriptional complex as a therapeutic target in cancer

Por Blevins, Melanie A, Towers, Christina Garlington, Patrick, Aaron N., Zhao, Rui, Ford, Heide L.
Publicado no Expert Opin Ther Targets (2015)

Abrogation of the G(2) cell cycle checkpoint associated with overexpression of HSIX1: A possible mechanism of breast carcinogenesis

Por Ford, Heide L., Kabingu, Edith N., Bump, Edward A., Mutter, George L., Pardee, Arthur B.
Publicado em 1998

TRAIL Receptor Signaling Regulation of Chemosensitivity In Vivo but Not In Vitro

Por Menke, Christina, Goncharov, Tatiana, Qamar, Lubna, Korch, Christopher, Ford, Heide L., Behbakht, Kian, Thorburn, Andrew
Publicado em 2011

EWS/FLI1 regulates EYA3 in Ewing's sarcoma via modulation of microRNA-708, resulting in increased cell survival and chemoresistance

Por Robin, Tyler P, Smith, Anna, McKinsey, Erin, Reaves, Lisa, Jedlicka, Paul, Ford, Heide L.
Publicado em 2012

On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics

Por Dimberg, Lina Y., Anderson, Charles K., Camidge, Ross, Behbakht, Kian, Thorburn, Andrew, Ford, Heide L.
Publicado no Oncogene (2012)

Structure-Function Analyses of the Human SIX1–EYA2 Complex Reveal Insights into Metastasis and BOR Syndrome

Por Patrick, Aaron N, Cabrera, Joshua H, Smith, Anna L, Chen, Xiaojiang S, Ford, Heide L, Zhao, Rui
Publicado em 2013

Non-cell-autonomous Effects of Autophagy Inhibition in Tumor Cells Promote Growth of Drug-resistant Cells

Por Thorburn, Jacqueline, Staskiewicz, Leah, Goodall, Megan L., Dimberg, Lina, Frankel, Arthur E., Ford, Heide L., Thorburn, Andrew
Publicado no Mol Pharmacol (2017)

CDK6 binds and promotes the degradation of the EYA2 protein

Por Kohrt, Dawn, Crary, Jennifer, Zimmer, Marc, Patrick, Aaron N, Ford, Heide L, Hinds, Philip W, Grossel, Martha J
Publicado em 2014

The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer

Por Smith, Anna L., Iwanaga, Ritsuko, Drasin, David J., Micalizzi, Douglas S., Vartuli, Rebecca L, Tan, Aik-Choon, Ford, Heide L.
Publicado em 2012